| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |